The new identity will enable the agency to draw on the expertise of its staff across digital, CRM, branding, experiential, media, retail, PR and production disciplines within the DDB Mudra Group and the DDB network overseas.
DDB Remedy India, led by president Soumitra Sen, will continue to build on its practice including healthcare services communication, diagnostic & devices brand building, fast moving health goods (FMHG) & over-the-counter (OTC) strategising, medical prescription or doctor office brand campaigns and development communication.
Sen told Campaign Asia-Pacific that the biggest change of rebranding would be ease of access to global learning and experience, as well as leading to global business alignments.
He pointed out that healthcare practice in India is the challenge of a low cost cluttered branded generic environment with prices being one of the lowest in the world.
"It also comes with multiple advantages of a fast growing market for healthcare services, diagnostics and devices, consumer healthcare and development communication," Sen said. "We feel that the overall healthcare scenario is just entering a robust growth phase. Becoming a member of the worldwide network will help DDB Remedy India provide cutting-edge creative brand consulting solutions to our clients."
The rechristening in India marks the beginning of DDB Remedy’s regional rebranding, which will roll out next week.
DDB Remedy was launched in 2010 by the New York offices of DDB Worldwide. Today, there are more than 40 DDB offices around the world that offer dedicated healthcare advertising, and provide communications for all aspects of health and pharmaceuticals.